Hiroko Ikeda
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Diseases and Immunity
- Liver physiology and pathology
- Oncology top 5%
- Cancer Cells and Metastasis
Papers in
- Hepatology 22
- Liver Diseases and Immunity 10
- Hepatocellular Carcinoma Treatment and Prognosis 8
- Oncology 28
- Pancreatic and Hepatic Oncology Research 9
- Co-authors
- Yasuni Nakanuma (32 shared papers)Yasunori Sato (32 shared papers)Motoko Sasaki (21 shared papers)Kenichi Harada (30 shared papers)Norihide Yoneda (12 shared papers)Yasuni Nakanuma (7 shared papers)Saya Igarashi (6 shared papers)Akishi Ooi (12 shared papers)
- Journals
- Pathology International (7 papers)Human Pathology (7 papers)Frontiers in Oncology (4 papers)The Journal of Pathology (4 papers)Journal of Clinical Pathology (4 papers)
- Partner nations
- JapanSouth KoreaChina
In The Last Decade
Hiroko Ikeda
123 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 78
- Hepatology 784
- Oncology 442
- Pulmonary and Respiratory Medicine 481
- Surgery 621
- Cancer Research 154
Countries citing papers authored by Hiroko Ikeda
This map shows the geographic impact of Hiroko Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Ikeda more than expected).
Fields of papers citing papers by Hiroko Ikeda
This network shows the impact of papers produced by Hiroko Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Ikeda. The network helps show where Hiroko Ikeda may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroko Ikeda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 136 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 245 | |
| 2 | 2005 | 103 | |
| 3 | 2012 | 91 | |
| 4 | 2012 | 88 | |
| 5 | 2012 | 84 | |
| 6 | 2010 | 80 | |
| 7 | 2006 | 77 | |
| 8 | 2014 | 74 | |
| 9 | 2008 | 70 | |
| 10 | 2013 | 66 | |
| 11 | 2012 | 60 | |
| 12 | 2007 | 54 | |
| 13 | 2007 | 54 | |
| 14 | 2010 | 54 | |
| 15 | Utility of fluorescence in situ hybridization to detect MDM2 amplification in liposarcomas and their morphological mimics. | 2013 | 54 |
| 16 | 2012 | 53 | |
| 17 | 2013 | 49 | |
| 18 | 2009 | 47 | |
| 19 | 2011 | 46 | |
| 20 | 2012 | 46 |
About Hiroko Ikeda
Hiroko Ikeda is a scholar working on Hepatology, Oncology, Pulmonary and Respiratory Medicine, Rheumatology and Surgery, having authored 136 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers), Sarcoma Diagnosis and Treatment (12 papers), Liver Diseases and Immunity (10 papers), Pancreatic and Hepatic Oncology Research (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers), IgG4-Related and Inflammatory Diseases (7 papers), MRI in cancer diagnosis (6 papers) and Neuroendocrine Tumor Research Advances (5 papers). The work is most often cited by research in Hepatology (784 citations), Oncology (442 citations), Pulmonary and Respiratory Medicine (481 citations), Surgery (621 citations) and Cancer Research (154 citations). Hiroko Ikeda has collaborated with scholars based in Japan, South Korea and China. Frequent co-authors include Yasuni Nakanuma, Yasunori Sato, Motoko Sasaki, Kenichi Harada, Norihide Yoneda, Yasuni Nakanuma, Saya Igarashi, Akishi Ooi, Yoh Zen and S Kitamura. Their work appears in journals such as Pathology International, Human Pathology, Frontiers in Oncology, The Journal of Pathology and Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.